Terray Therapeutics seals $60m Series A
Terray Therapeutics, a biotechnology company, has closed $60 million in Series A financing.
Terray Therapeutics, a biotechnology company, has closed $60 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination